Investor Presentation First Nine Months of 2023

120 Investor presentation First nine months of 2023 GLP-1 market share and market growth in EMEA 80% 60% 40% 20% GLP-1 market growth and Novo Nordisk market share 0% Aug 2020 DKK billion 80% 71% 63% 60% 23 44% 40% 37% 20% 60% GLP-1 market size and growth -37% 3 6 EMEA 32 2 ~44% 63% 0% Aug 2023 Aug Aug Novo Nordisk Company A Others 2022 2023 Novo Nordisk Competitors NN market share -Market growth (right axis) -NN share of growth -NN growth (right axis) Source: IQVIA, Aug 2023, Value, MAT; Due to contractual obligations competitor names are not disclosed. Company A represents an actual company. EMEA: Europe, Middle East and Africa; NN: Novo Nordisk; Market values are based on the list prices

View entire presentation